Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria

Main Article Content

Maryam Sadr
Neda Khalili
Bahareh Mohebbi
Banafsheh Mosharmovahed
Parivash Afradi
Nima Rezaei

Keywords

Urticaria, Gene Polymorphism, PTPN22, Chronic spontaneous urticaria.

Abstract

Introduction and objectives: Chronic spontaneous urticaria (CSU) is thought to be an auto-immune disease in a subpopulation of patients. Protein tyrosine phosphatase-22 (PTPN22) polymorphisms are considered to be one of the strongest contributing factors to autoimmune diseases. In this study, we aimed to investigate the potential association of several PTPN22 single nucleotide polymorphisms (SNPs) with CSU in an Iranian population.
Material and methods: A total of 93 CSU patients and 100 healthy individuals were included in this study. Five SNPs within the PTPN22 gene were analyzed using TaqMan genotyping assays. The frequency of alleles, genotypes, and haplotypes of PTPN22 SNPs (rs12760457, rs2476601, rs1310182, rs1217414, and rs33996649) was investigated.
Results: A significantly higher prevalence of the rs1310182 T allele was observed among patients compared with controls [OR = 1.75 (95% CI: 1.17–2.63); P = 0.007]. In addition, the rs1310182 CC genotype and TT genotype were 0.47 and 2.06 times more common in patients, respectively (P = 0.03). Moreover, haplotype analysis demonstrated that CGCGC, CGTGC, and TGCGC (P < 0.001) were significantly associated with CSU. No significant differences were observed between the patients and controls in the other analyzed PTPN22 SNPs.
Conclusions: Polymorphisms of the PTPN22 gene are associated with an increased susceptibility to CSU in the studied Iranian population.

Abstract 262 | PDF Downloads 157 XML Downloads 4 HTML Downloads 3

References

1. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–1414. https://doi. org/10.1111/all.13397

2. Amar SM, Dreskin SC. Urticaria. Prim Care. 2008;35:141–157. https://doi.org/10.1016/j.pop.2007.09.009

3. McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006;142:1337–1342. https://doi. org/10.1001/archderm.142.10.1337

4. Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Brit J Dermatol. 2016;174:996–1004. https://doi.org/10.1111/bjd.14470

5. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–672.https://doi.org/10.1067/mai.2000.105706

6. Gaig P, Olona M, Lejarazu D, Caballero T, Domínguez F, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol. 2004;14:214–220.

7. Grattan CEH, Borzova E. Urticaria, angioedema, and anaphylaxis. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors. Clinical immunology. 5th edition. London: Elsevier; 2019. p. 585.e1–600.e1. https://doi. org/10.1016/B978-0-7020-6896-6.00042-9

8. Greaves MW. Chronic urticaria. NEJM. 1995;332:1767–1772. https://doi.org/10.1056/NEJM199506293322608

9. Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology. 2012;224:340–345. https://doi.org/10.1159/ 000339332

10. Kanani A, Betschel SD, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. 2018;14:59. https://doi.org/10.1186/s13223-018-0288-z

11. Poonawalla T, Kelly B. Urticaria: a review. Am J Clin Dermatol. 2009;10:9–21. https://doi.org/10.2165/0128071-200910010-00002

12. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CEH, et al. Classification of anti-Fc epsilon RI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002;110:492–499. https://doi.org/10.1067/mai.2002.126782

13. Beck LA, Bernstein JA, Maurer M. A review of international recommendations for the diagnosis and management of chronic urticaria. Acta dermato-venereologica. 2017;97:149– 158. https://doi.org/10.2340/00015555-2496

14. Nettis E, Foti C, Ambrifi M, Baiardini I, Bianchi L, Borghi A, et al. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology. Clin Mol Allergy. 2020;18. Article no. 8. https:// doi.org/10.1186/s12948-020-00123-8

15. Kikuchi Y, Fann T, Kaplan AP. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol. 2003;112:218. https://doi.org/10.1067/mai.2003.1605

16. Viswanathan RK, Biagtan MJ, Mathur SK. The role of autoimmune testing in chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108:337.e1–341.e1. https://doi.org/ 10.1016/j.anai.2012.02.018

17. Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol. 2002;89:195–196. https://doi. org/10.1016/S1081-1206(10)61937-0

18. Losol P, Yoo H-S, Park H-S. Molecular genetic mechanisms of chronic urticaria. Allergy Asthma Immunol Res. 2014;6:13–21. https://doi.org/10.4168/aair.2014.6.1.13

19. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68:27–36. https://doi.org/10.1111/all.12056

20. Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, et al. Genetic association of PTPN22 polymorphisms with autoimmune hepatitis and primary biliary cholangitis in Japan. Sci Rep. 2016;6:1–6. https://doi.org/10.1038/ srep29770

21. Budding K, Van Setten J, Van De Graaf EA, Van Rossum OA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, et al. The autoimmune-associated single nucleotide polymorphism within PTPN22 correlates with clinical outcome after lung transplantation. Front Immunol. 2019;9:3105. https://doi.org/10.3389/ fimmu.2018.03105

22. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76:561–571. https://doi. org/10.1086/429096

23. Velaga M, Wilson V, Jennings C, Owen C, Herington S, Donaldson P, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab. 2004;89:5862–5865. https://doi.org/10.1210/jc.2004-1108

24. Brzoza Z, Grzeszczak W, Trautsolt W, Moczulski D. Protein tyrosine phosphatase-22 (PTPN-22) polymorphism in the pathogenesis of chronic urticaria. Allergy. 2011;66:1392–1393. https://doi.org/10.1111/j.1398-9995.2011.02651.x

25. Houcken J, Degenhart C, Bender K, König J, Frommer L, Kahaly GJ. PTPN22 and CTLA-4 polymorphisms are associated with polyglandular autoimmunity. J Clin Endocrinol Metab. 2018;103:1977–1984. https://doi.org/10.1210/jc.2017-02577

26. Di Pietro F, Ortenzi F, Tilio M, Concetti F, Napolioni V. Genomic DNA extraction from whole blood stored from 15-to 30-years at −20°C by rapid phenol-chloroform protocol: a useful tool for genetic epidemiology studies. Mol Cell Probes. 2011;25:44–48. https://doi.org/10.1016/j.mcp.2010.10.003

27. Hide M, Francis DM, Grattan C, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. NEJM. 1993;328:1599–1604. https://doi.org/10.1056/ NEJM199306033282204

28. Grattan C, Francis D, Hide M, Greaves M. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy. 1991;21:695–704. https://doi.org/10.1111/j.1365-2222.1991.tb03198.x

29. Guo J, Rapoport B, McLachlan SM. Thyroid peroxidase auto-antibodies of IgE class in thyroid autoimmunity. Clin Immunol Immunopathol. 1997;82:157–162. https://doi.org/10.1006/ clin.1996.4297

30. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703. https://doi.org/10.1038/ ng.381

31. Zheng J, Ibrahim S, Petersen F, Yu X. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immun. 2012;13:641–652. https://doi.org/10.1038/ gene.2012.46

32. Lee A, Li W, Liew A, Bombardier C, Weisman M, Massarotti E, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005;6:129–133. https://doi.org/10.1038/sj.gene.6364159

33. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36:337–338. https://doi.org/10.1038/ng1323

34. Begovich AB, Carlton VEH, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004;75:330–337. https://doi. org/10.1086/422827

35. Rhee I, Veillette A. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol. 2012;13:439. https://doi.org/10.1038/ni.2246

36. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med. 1999;189:111–121. https://doi. org/10.1084/jem.189.1.111

37. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454–460. https://doi.org/10.1038/nature02119

38. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 cor-responds to altered function of T and B lymphocytes. J Immunol. 2007;179:4704–4710. https://doi.org/10.4049/ jimmunol.179.7.4704

39. Vang T, Congia M, Macis MD, Musumeci L, Orrú V, Zavattari P, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 2005;37:1317–1319. https://doi.org/10.1038/ng1673

40. Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G, et al. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy. 2005;35:221–225. https://doi. org/10.1111/j.1365-2222.2005.02168.x

41. Bhattacharyya SP, Drucker l, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol. 1998;63:337–341. https://doi.org/10.1002/jlb.63.3.337

42. Hidvégi B, Nagy E, Szabó T, Temesvári E, Marschalkó M, Kárpáti S, et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol. 2003;132:177–182. https://doi.org/10.1159/000073719

43. Auyeung P, Mittag D, Hodgkin PD, Harrison LC. Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit. J Allergy Clin Immunol. 2016;138:761.e4–768.e4. https://doi.org/10.1016/j.jaci.2016.04.036

44. Kaplan AP. Chronic spontaneous urticaria: pathogenesis and treatment considerations. Allergy Asthma Immunol Res. 2017;9:477–482. https://doi.org/10.4168/aair.2017.9.6.477